Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies.

Lin, X; Lu, Z G; Song, C Y; Huang, Y X; Guo, K Y; Deng, L; Tu, S F; He, Y Z; Xu, J H; Long, H; Wu, B Y

Lin, X; Lu, Z G; Song, C Y; Huang, Y X; Guo, K Y; Deng, L; Tu, S F; He, Y Z; Xu, J H; Long, H; Wu, B Y.

Afiliación

Lin X; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Lu ZG; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Song CY; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Huang YX; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Guo KY; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Deng L; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Tu SF; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
He YZ; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Xu JH; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Long H; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.
Wu BY; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong province, People's Republic of China.

Bone Marrow Transplant ; 50(8): 1092-7, 2015 Aug.

Article en En | MEDLINE | ID: mdl-25961770

Asunto(s)

Neoplasias Hematológicas/mortalidad; Neoplasias Hematológicas/terapia; Trasplante de Células Madre Hematopoyéticas; Depleción Linfocítica/métodos; Linfocitos T; Acondicionamiento Pretrasplante/métodos; Adolescente; Adulto; Aloinjertos; Busulfano/administración & dosificación; Niño; Ciclofosfamida/administración & dosificación; Supervivencia sin Enfermedad; Femenino; Estudios de Seguimiento; Prueba de Histocompatibilidad; Humanos; Masculino; Persona de Mediana Edad; Tasa de Supervivencia; Vidarabina/administración & dosificación; Vidarabina/análogos & derivados

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Depleción Linfocítica / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Acondicionamiento Pretrasplante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google